Ex-Cel­gene ex­ec Ter­rie Cur­ran puts her Phath­om team in place; Car­away taps Mar­tin Williams as CEO

→ Gas­troin­testi­nal dis­ease-fo­cused Phath­om Phar­ma­ceu­ti­cals has shak­en up its lead­er­ship team. The com­pa­ny has tapped for­mer Cel­gene ex­ec Ter­rie Cur­ran as CEO, suc­ceed­ing David Socks, who is tran­si­tion­ing to in­ter­im CFO. Cur­ran was pres­i­dent of Cel­gene’s glob­al in­flam­ma­tion and im­munol­o­gy fran­chise — help­ing with the sale of Ote­zla for $13.4 bil­lion to Am­gen — and has held a pre­vi­ous stint at Mer­ck. In ad­di­tion to Cur­ran, the com­pa­ny al­so wel­comed for­mer Omeros CMO Eck­hard Leifke as CMO, ex-Cel­gene ex­ec Joseph Hand as chief ad­min­is­tra­tive of­fi­cer, and for­mer gen­er­al coun­sel for Cy­cle­ri­on Ther­a­peu­tics Lar­ry Miller as gen­er­al coun­sel. They al­so re­placed Chris Slavin­sky on the board with Take­da ex­ec Asit Parikh.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER